Di-O-lauroyl-decitabine-lipid nanocapsules: toward extending decitabine activity

BACKGROUND: Acute myeloid leukemia mainly affects adult patients. Complete remission for patients younger than 60 years, who are candidates for standard induction therapy, is achieved in 60%–80% of cases. However, the prognosis is still poor for older patients, who are unfit for intensive chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Briot, Thomas, Roger, Emilie, Bou Haidar, Naila, Bejaud, Jerome, Lautram, Nolwenn, Guillet, Catherine, Thépot, Sylvain, Legeay, Samuel, Lagarce, Frederic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440450/
https://www.ncbi.nlm.nih.gov/pubmed/30988610
http://dx.doi.org/10.2147/IJN.S190482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440450/
https://www.ncbi.nlm.nih.gov/pubmed/30988610
http://dx.doi.org/10.2147/IJN.S190482

Ejemplares similares